Published 17:38 IST, March 18th 2024
AstraZeneca limits out-of-pocket inhaler costs to $35 per month
The $35 cap will be applicable to AstraZeneca's entire respiratory products portfolio, including inhalers used in the treatment of asthma.
AstraZeneca | Image:
Unsplash
- Listen to this article
- 1 min read
Advertisement
17:38 IST, March 18th 2024